Pharos Capital Promotes Partner and Three Associates

Pharos Capital Group, LLC, a physician-founded healthcare private equity firm based in Dallas and Nashville, has made a number of key promotions.

The firm has promoted Anna Kovalkova – based in the firm’s Nashville office and was most recently a Principal – to Partner. Concurrently, Pharos promoted three Senior Financial Analysts to Associates. They are Lauren Gurley and Kevin Ryan, based in Nashville, and Jim Kerrigan in Dallas.

Ms. Kovalkova is responsible for leading the evaluation, due diligence and execution of investments as well as for overseeing portfolio companies. She currently serves on the boards of Back Yard Burgers, Beacon Specialized Living Services, Sona Dermatology & Medspa, Seaside Healthcare, and TotalTrax.
The Associates are responsible for evaluating and executing investment opportunities, performing transaction due diligence, and working with management teams to implement operational and growth strategies.
Ms. Gurley currently works with the firm’s investments in Beacon Specialized Living Services, Employee Benefit Solutions and Back Yard Burgers. Before joining Pharos, she was an Investment Banking Analyst at MHT Partners in Dallas. She holds a BBA in Finance from Southern Methodist University.
Mr. Kerrigan works with the firm’s investments in Sona Dermatology & Medspa, Egenera, FasPsych, and MOTION Physical Therapy. Prior to joining Pharos, he spent two years as an Investment Banking Analyst at Barclays in New York.
Mr. Ryan works with the firm’s investments in Alereon, Reel FX and Seaside Healthcare. Before coming to Pharos, he worked as an Investment Banking Analyst for Stephens Inc. in Little Rock.

Led by Founding Partners Kneeland Youngblood and Bob Crants, Pharos Capital Group is an SEC Registered Investment Advisor that has invested in 50 companies. The firm, which currently has approximately $730m of private equity assets under management, typically invests $25-$50 million in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations predominantly across healthcare sectors.



Join the discussion